PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support

New industry support enables the team to expand their search and validation of diagnostic biomarkers to shed light on asthma with thus far unexplained causes and improve therapy

Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support
2024-12-16
(Press-News.org)

Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support

New industry support enables the team to expand their search and validation of diagnostic biomarkers to shed light on asthma with thus far unexplained causes and improve therapy 

By Benjamin Boettner

(BOSTON) – Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day. Many of these deaths could be prevented if patients had timely access to the appropriate therapy following an accurate diagnosis.

Driven by an acute sense of urgency to close this diagnostic gap, a research collaboration between clinical immunologist Tanya Laidlaw, M.D. at Brigham and Women’s Hospital (BWH) in Boston and Rushdy Ahmad, Ph.D., Director of the Diagnostics Accelerator (DxA) at the Wyss Institute at Harvard University set out to shed new light on causes of asthma that defy known categories and thus far remain unexplained and thus untreatable and to eventually pave the way towards a diagnostic test that is able to distinguish between different forms of asthma. The team has now received a grant from Sanofi that will allow them to expand upon an initial set of distinguishing protein biomarkers identified in a pilot study across a significantly larger patient cohort. 

Many of us have experienced with friends or family, or even ourselves the alarming symptoms of asthma: the typical trouble breathing, wheezing, coughing, and tightness or pain in the chest. However, asthma can have very different inflammatory causes that must be differently treated in order to help or even rescue patients. “Being able to precisely pinpoint the type of asthma a patient is suffering from with a simple yet highly specific test remains a critical unmet need in respiratory medicine. Clear results that can distinguish different types of asthma would also greatly improve treatment courses and potentially lead to new ones,” said Laidlaw. “I am thrilled about the opportunities that have opened up now thanks to the Wyss DxA’s exceptional capabilities and organization, and to the grant support from Sanofi which will allow us to take our studies to the next level.” Laidlaw is the Director of Translational Research at BWH’s Division of Allergy and Clinical Immunology, and Associate Professor at Harvard Medical School (HMS).

To dramatically accelerate the development of next-generation diagnostics, the Wyss DxA takes its cues directly from clinicians from the clinical community at the BWH in Boston, such as Laidlaw, who experience the lack of diagnostic capabilities first-hand and can provide deep insights into patients’ histories and diseases. Fortified with this knowledge, and with access to high-quality patient samples, the Wyss DxA then brings its capabilities to bear on the problems at hand. In the asthma project, the Wyss DxA’s Biomarker Discovery Laboratory (BDL) played a crucial role, as the lack of specific molecular biomarkers for asthma and other underexplored diseases has hindered the development of clinical diagnostic tests. “Our asthma-focused partnership with Dr. Laidlaw maximizes our combined strengths in advanced biomarker discovery and clinical validation, aiming to establish a new translational pathway that will accelerate the development of a critically needed diagnostic test,” said Ahmad, who conceptualized the project with Laidlaw. Ahmad coordinates all of the Wyss DxA’s collaborations with clinicians at BWH in close partnership with James (Trey) Toombs, Ph.D., Program Director at the BWH, and Head of Operations of the Wyss DxA’s Industrial Participant Program (IPP).

Asthma intricacies

Clinical asthma researchers have started to embrace the concept of “endotyping” to classify patients’ asthma disease into distinct subtypes based on their underlying molecular features, but they need more help to do this efficiently. Asthma often is associated with a type of inflammation in the lungs that is known as type 2 inflammation (T2-high), which the immune system may have originally evolved to fight pathogens but that can also go into overdrive to trigger asthmatic and allergic conditions. Typically, patients with T2-high asthma exhibit increased numbers of an immune cell called eosinophils and/or increased levels of the antibody immunoglobulin E (IgE) in their blood. Both of these can be clinically measured in blood samples with the caveats that high eosinophils and IgE levels in patients’ blood can occur independent of processes taking place in their lungs, and that elevated IgE and eosinophil levels can also occur in patients who do not have asthma. 

Importantly, the two broader groups of available asthma drugs work by lowering either eosinophils or IgE, or the type 2 inflammatory pathways leading to their production. However, there remains a significant number of asthma patients who, despite being T2-high and having increased numbers of eosinophils and/or IgE levels, don’t respond to the available therapies, as well as asthma patients who lack type 2 inflammation (T2-low) altogether and therefore do not exhibit abnormally high levels of eosinophils or IgE. This led asthma researchers to the realization that another type of inflammation must be at work that cannot be therapeutically targeted yet.

“In reality, asthma is a very heterogenous condition and, thus far, we don’t have the diagnostic means to quickly determine which patients develop asthma symptoms because of inflammation in their lungs that is different from type 2 inflammation and might require new therapies,” said Laidlaw. “Being able to easily and accurately ‘fingerprint’ different forms of asthma based on different biomarker signatures would dramatically improve the treatment course doctors could prescribe to many of their asthma patients,” said Laidlaw.

The power of biomarkers 

After Laidlaw had proposed the diagnostic asthma challenge, the strategic plan laid out by her and Ahmad first sought to address the problem in a pilot study. Bringing further attention to the matter and their collaborative effort, Laidlaw, in 2023, also discussed the critical need for biomarkers that can immunologically characterize patients with asthma and other respiratory diseases and the strategic plan to address the problem at the Diagnostic Grand Rounds (DGRs). The regularly held DGRs are hosted by Wyss DxA’s Faculty Lead David Walt, Ph.D. to enable the Wyss’ engineering and BWH’s clinical communities to explore common grounds across a broad variety of clinical disciplines. 

In their pilot study, Laidlaw and Ahmad asked whether they could use nasal fluid to identify molecular biomarkers whose altered levels could provide a direct read-out for respiratory inflammatory processes in the lung, and help differentiate between different types of asthma. Laidlaw and Ahmad designed their small cohort-size pilot study to specifically identify biomarkers in the nasal fluid of uncategorized asthma patients with allergic symptoms vs patients plagued by allergies alone. This allowed them to subtract inflammatory and other biomarkers in the lung that are not directly associated with asthma. Ahmad performed a state-of-the-art ‘proteomics’ analysis at the Wyss DxA’s BDL together with proteomics expert and Wyss Principal Scientist Bogdan Budnik, Ph.D., and Wyss Research Assistant Shad Morton, and they succeeded in identifying a set of potential biomarker candidates. 

“If the question is asked correctly and if clinical samples exist to answer the question, then even a small cohort size pilot study can result in compelling results that can pave the path forward,“ Ahmad emphasized. “In this process, we optimized an analytical approach to detect biomarkers in nasal fluid and, with our concept and the first potential ‘hits,’ we submitted a grant proposal to Sanofi which we knew had a strong asthma program,” explained Ahmad. “Sanofi decided to support our study, which we are now excited to fast-track and expand.”

“This promising project with Tanya Laidlaw for which we have now obtained substantial industry support embodies a mechanism the DxA deploys to specifically accelerate the early development of critical precision diagnostics,” said Wyss Core Faculty member Walt. “Importantly, among validated biomarkers that can clearly identify asthma patients whose disease is not driven by a type 2 inflammatory immune response, there could be novel therapeutic targets whose inhibition may become the basis of future needed therapies for this patient group.” Walt is also the Hansjörg Wyss Professor of Biologically Inspired Engineering at HMS, Professor of Pathology at BWH, and a Howard Hughes Medical Institute Professor.

Media contact

Benjamin Boettner, Ph.D., Wyss Institute, Benjamin.Boettner@wyss.harvard.edu

###

The Wyss Institute for Biologically Inspired Engineering at Harvard University (www.wyss.harvard.edu) is a research and development engine for disruptive innovation powered by biologically-inspired engineering with visionary people at its heart. Our mission is to transform healthcare and the environment by developing ground-breaking technologies that emulate the way Nature builds and accelerate their translation into commercial products through formation of startups and corporate partnerships to bring about positive near-term impact in the world. We accomplish this by breaking down the traditional silos of academia and barriers with industry, enabling our world-leading faculty to collaborate creatively across our focus areas of diagnostics, therapeutics, medtech, and sustainability. Our consortium partners encompass the leading academic institutions and hospitals in the Boston area and throughout the world, including Harvard’s Schools of Medicine, Engineering, Arts & Sciences and Design, Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Boston Children’s Hospital, Dana–Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Boston University, Tufts University, Charité – Universitätsmedizin Berlin, University of Zürich, and Massachusetts Institute of Technology.

 

 

END


[Attachments] See images for this press release:
Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support 2 Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support 3

ELSE PRESS RELEASES FROM THIS DATE:

Towards smart cities: Integrating ground source heat pump systems with energy piles

Towards smart cities: Integrating ground source heat pump systems with energy piles
2024-12-16
Human civilization is currently evolving at an unprecedented rate, with new breakthroughs every single day. This has become possible due to never-tapped-before levels of energy resources. However, the unsustainable development has recently raised concerns about adverse effects on the environment, resulting in a growing urgency to address issues pertaining to energy efficiency and climate change, especially in urban environments. Notably, rapid urbanization has worsened the urban heat island effect, a phenomenon where a city experiences significantly warmer temperatures than ...

Emotional cognition analysis enables near-perfect Parkinson's detection

Emotional cognition analysis enables near-perfect Parkinsons detection
2024-12-16
A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain responses to emotional situations like watching video clips or images. The findings offer an objective way to diagnose the debilitating movement disorder, instead of relying on clinical expertise and patient self-assessments, potentially enhancing treatment options and overall well-being for those affected by Parkinson's disease. The study was published Oct. 17 in Intelligent ...

Treating prostate cancer with novel platinum complex via targeting androgen receptor signaling

Treating prostate cancer with novel platinum complex via targeting androgen receptor signaling
2024-12-16
Prostate cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer among men. Although treatments like androgen deprivation therapy have been effective for early-stage prostate cancer, advanced stages, such as castration-resistant prostate cancer, present significant treatment challenges due to resistance to therapies. Current approaches targeting androgen receptor (AR) signaling, such as taxanes and newer agents, show limited success. Cisplatin, a widely used anticancer drug, has been used in combination therapies but its use is limited by severe ...

Breaking barriers: Study uses AI to interpret American Sign Language in real-time

Breaking barriers: Study uses AI to interpret American Sign Language in real-time
2024-12-16
Sign language serves as a sophisticated means of communication vital to individuals who are deaf or hard-of-hearing, relying on hand movements, facial expressions, and body language to convey nuanced meaning. American Sign Language exemplifies this linguistic complexity with its distinct grammar and syntax. Sign language is not universal; rather, there are many different sign languages used around the world, each with its own grammar, syntax and vocabulary, highlighting the diversity and complexity of sign languages globally. Various ...

University of Texas at San Antonio launches new center to propel space technology

University of Texas at San Antonio launches new center to propel space technology
2024-12-16
UTSA’s Office of Research today announced the launch of the Center for Space Technology and Operations Research (CSTOR), a new research center dedicated to advancing engineering, technology and operations that will support space missions between the Earth and the Moon, an area referred to as cislunar space, as well as the lunar surface. The center will address the growing demand for research and workforce development by civil, commercial and national security space agencies and companies. David Silva, UTSA distinguished professor of physics and astronomy, will serve as the center’s inaugural director. CSTOR will provide enhanced support ...

Every cell has a story: Tumor and immune cell interactions within craniopharyngiomas

Every cell has a story: Tumor and immune cell interactions within craniopharyngiomas
2024-12-16
Craniopharyngioma (CP) is a rare brain tumor that develops in the regions close to the hypothalamus and pituitary gland. The CP tumors lead to complications like defective vision, neuronal defects, diabetes, and developmental problems. There are two primary subtypes of CPs: adamantinomatous craniopharyngioma (ACP) and papillary craniopharyngioma (PCP). These two subtypes are distinguished by their distinct genetic profiles. ACP is typically characterized by mutations in the CTNNB1 gene, while PCP is primarily associated with BRAF gene mutations. The primary course of action for treating CP is surgical intervention. However, the tumor's invasive ...

Single-stream image-to-image translation (SSIT): a more efficient approach to image translation

Single-stream image-to-image translation (SSIT): a more efficient approach to image translation
2024-12-16
Among the many artificial intelligence and machine learning models available today for image translation, image-to-image translation models using Generative Adversarial Networks (GANs) can change the style of images. These models work by using two input images: a content image, which is altered to match the style of a reference image. These models are used for tasks like transforming images into different artistic styles, simulating weather changes, improving satellite video resolution, and helping autonomous vehicles recognize different lighting conditions, like day and night.   Now, researchers ...

Flavonoid powerhouse: kaempferol's role in taming allergic responses

Flavonoid powerhouse: kaempferols role in taming allergic responses
2024-12-16
Allergic diseases such as asthma, atopic dermatitis, and food allergies have been increasing in frequency over the last few years. Food allergies in particular affect millions of people worldwide—this includes allergies to foods such as milk, peanuts, eggs and shellfish. They are typically caused by the immune system being hypersensitive to harmless substances in foods and the environment. Flavonoids are chemicals present in various fruits and vegetables that are known to have anti-allergic effects and show promise as natural allergic treatments. To better understand how these allergies can be treated, let’s look at an interesting anti-allergic mechanism in our cells. ...

It’s worth mixing it up: what combination of policies will lead to a clean energy future?

2024-12-16
How can we ensure that as many households as possible adopt not only solar panels, but also their own battery to store solar energy, a heat pump, and an electric car? Researchers at the Universities of Basel and Geneva have looked into just this question. Climate protection and the energy revolution must continue to make progress, and private households could make a significant contribution to this goal if they would use environmentally friendly technologies such as solar panels, electric vehicles, and heat pumps. Dr. Mart van der Kam and Professor Ulf Hahnel at the University of Basel, Switzerland, conducted research into the political measures that would be necessary to fully realize ...

Human civilization at a critical junction between authoritarian collapse and superabundance

2024-12-16
A new scientific study published in the journal Foresight concludes that human civilisation is on the brink of the next ‘giant leap’ in evolution. However, progress could be thwarted by centralised far-right political projects such as the incoming Donald Trump administration.  "Industrial civilisation is facing 'inevitable' decline as it is replaced by what could turn out to be a far more advanced ‘postmaterialist’ civilisation based on distributed superabundant clean energy. The main challenge is that industrial civilisation is facing such rapid decline that this could derail the emergence of a ...

LAST 30 PRESS RELEASES:

Sex differences in brain structure present at birth

UCLA scientist unlocks early warning signs of adolescent psychosis through genetics

Research reveals unique features of brain cells linked to neurodevelopmental conditions

Smarter memory: next-generation RAM with reduced energy consumption

Core-membrane microstructured amine-modified mesoporous biochar templated via ZnCl2/KCl for CO2 capture

Audio-guided self-supervised learning for disentangled visual speech representations

From logs to security: How process analysis is transforming access control

Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo

Photonic nanojet-regulated soft microalga-robot

How do directional connections shape complex dynamics in neuronal networks?

Drug-resistant hookworms put pets and people at risk

New strontium isotope map of Sub-Saharan Africa is a powerful tool for archaeology, forensics, and wildlife conservation

‘Sandwich carers’ experience decline in mental and physical health

A new way to determine whether a species will successfully invade an ecosystem

A change in the weather in the U.S. Corn Belt

How we classify flood risk may give developers, home buyers a false sense of security

GLP-1 drugs may reduce surgery complications in patients with diabetes

Physicists explain a stellar stream’s distinctive features

GLP-1 RA medications safe and very effective for treating obesity in adults without diabetes

Efforts to reduce kids' screen time weakened by unequal access to green space

Study reveals rising interest in permanent contraception after Roe v. Wade was overturned

U of M Medical School study finds point-of-care ultrasound enhances early pregnancy care, cuts emergency visits by 81%

Ice patches on Beartooth Plateau reveal how ancient landscape differed from today’s

MMRI scientist publishes breakthrough study detailing how ketones improves blood flow to the heart

2025 Seismological Society of America Annual Meeting

New AI tool uses routine blood tests to predict immunotherapy response for many cancers

1 in 4 U.S. veterans aged 60+ report having being diagnosed with cardiovascular disease at some point, with potential implications for their physical and mental health

These 11 genes may help us better understand forever chemicals’ effects on the brain

Microplastics widespread in seafood people eat

Lead pollution likely caused widespread IQ declines in ancient Rome, new study finds

[Press-News.org] Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support
New industry support enables the team to expand their search and validation of diagnostic biomarkers to shed light on asthma with thus far unexplained causes and improve therapy